Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.

Kuhar, M J; Carroll, F I; Bharat, N; Landry, D W

Kuhar, M J; Carroll, F I; Bharat, N; Landry, D W.

Affiliation

Kuhar MJ; Yerkes Regional Primate Center of Emory University, Atlanta, Georgia 30329, USA. mkuhar@rmy.emory.edu

Synapse ; 41(2): 176-8, 2001 Aug.

Article in En | MEDLINE | ID: mdl-11400184

Subject(s)

Antibodies, Catalytic/immunology; Antibody Affinity/drug effects; Cocaine-Related Disorders/drug therapy; Cocaine/analogs & derivatives; Cocaine/immunology; Tropanes/immunology; Adrenergic Uptake Inhibitors/pharmacology; Antibodies, Catalytic/chemistry; Antibodies, Catalytic/pharmacology; Antibody Affinity/physiology; Brain/drug effects; Brain/metabolism; Brain/physiopathology; Carrier Proteins/drug effects; Carrier Proteins/metabolism; Cocaine/pharmacology; Cocaine-Related Disorders/immunology; Cocaine-Related Disorders/physiopathology; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Mazindol/pharmacology; Tropanes/chemistry; Tropanes/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tropanes / Cocaine / Antibodies, Catalytic / Cocaine-Related Disorders / Antibody Affinity Language: En Journal: Synapse Journal subject: NEUROLOGIA Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links